These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 1388772)

  • 1. A quantitative structure-activity relationship for some dopamine D2 antagonists of benzamide type.
    Norinder U; Högberg T
    Acta Pharm Nord; 1992; 4(2):73-8. PubMed ID: 1388772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of dopamine D2-receptor selective antagonists.
    Högberg T
    Drug Des Discov; 1993; 9(3-4):333-50. PubMed ID: 8400011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QSAR modeling on dopamine D2 receptor binding affinity of 6-methoxy benzamides.
    Samanta S; Debnath B; Gayen S; Ghosh B; Basu A; Srikanth K; Jha T
    Farmaco; 2005 Oct; 60(10):818-25. PubMed ID: 16055122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GRID/GOLPE 3D quantitative structure-activity relationship study on a set of benzamides and naphthamides, with affinity for the dopamine D3 receptor subtype.
    Nilsson J; Wikström H; Smilde A; Glase S; Pugsley T; Cruciani G; Pastor M; Clementi S
    J Med Chem; 1997 Mar; 40(6):833-40. PubMed ID: 9083471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR prediction of D2 receptor antagonistic activity of 6-methoxy benzamides.
    Fatemi MH; Dorostkar F
    Eur J Med Chem; 2010 Nov; 45(11):4856-62. PubMed ID: 20728966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D3 and D4 receptor antagonists: synthesis and structure--activity relationships of (S)-(+)-N-(1-Benzyl-3-pyrrolidinyl)-5-chloro-4- [(cyclopropylcarbonyl) amino]-2-methoxybenzamide (YM-43611) and related compounds.
    Ohmori J; Maeno K; Hidaka K; Nakato K; Matsumoto M; Tada S; Hattori H; Sakamoto S; Tsukamoto S; Usuda S; Mase T
    J Med Chem; 1996 Jul; 39(14):2764-72. PubMed ID: 8709107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
    Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH
    J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-[2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl]-3-methoxybenzamide: a potent and selective dopamine D4 ligand.
    Perrone R; Berardi F; Colabufo NA; Leopoldo M; Tortorella V
    J Med Chem; 1998 Nov; 41(24):4903-9. PubMed ID: 9822559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 3D QSAR study on a set of dopamine D4 receptor antagonists.
    Boström J; Böhm M; Gundertofte K; Klebe G
    J Chem Inf Comput Sci; 2003; 43(3):1020-7. PubMed ID: 12767161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New benzamide-derived 5-HT3 receptor antagonists which prevent the effects of ethanol on extracellular dopamine, and fail to reduce voluntary alcohol intake in rats.
    Iusco G; Boido V; Sparatore F; Colombo G; Saba PL; Rossetti Z; Vaccari A
    Farmaco; 1997 Mar; 52(3):141-6. PubMed ID: 9212448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
    J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro affinities of various halogenated benzamide derivatives as potential radioligands for non-invasive quantification of D(2)-like dopamine receptors.
    Stark D; Piel M; Hübner H; Gmeiner P; Gründer G; Rösch F
    Bioorg Med Chem; 2007 Nov; 15(21):6819-29. PubMed ID: 17765546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin 5-HT2 receptor, dopamine D2 receptor, and alpha 1 adrenoceptor antagonists. Conformationally flexible analogues of the atypical antipsychotic sertindole.
    Andersen K; Liljefors T; Hyttel J; Perregaard J
    J Med Chem; 1996 Sep; 39(19):3723-38. PubMed ID: 8809161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194.
    Audinot V; Newman-Tancredi A; Gobert A; Rivet JM; Brocco M; Lejeune F; Gluck L; Desposte I; Bervoets K; Dekeyne A; Millan MJ
    J Pharmacol Exp Ther; 1998 Oct; 287(1):187-97. PubMed ID: 9765337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating dopamine D2 ligands by their sensitivities to modification of the cysteine exposed in the binding-site crevice.
    Javitch JA; Fu D; Chen J
    Mol Pharmacol; 1996 Apr; 49(4):692-8. PubMed ID: 8609898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc modulates antagonist interactions with D2-like dopamine receptors through distinct molecular mechanisms.
    Schetz JA; Chu A; Sibley DR
    J Pharmacol Exp Ther; 1999 May; 289(2):956-64. PubMed ID: 10215675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid state conformations and antidopaminergic effects of remoxipride hydrochloride and a closely related salicylamide, FLA 797, in relation to dopamine receptor models.
    Högberg T; Rämsby S; de Paulis T; Stensland B; Csöregh I; Wägner A
    Mol Pharmacol; 1986 Oct; 30(4):345-51. PubMed ID: 2945089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding.
    Metwally KA; Dukat M; Egan CT; Smith C; DuPre A; Gauthier CB; Herrick-Davis K; Teitler M; Glennon RA
    J Med Chem; 1998 Dec; 41(25):5084-93. PubMed ID: 9836624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational analysis of dopamine D-2 receptor antagonists of the benzamide series in relation to a recently proposed D-2 receptor-interaction model.
    Pettersson I; Liljefors T
    J Med Chem; 1992 Jun; 35(13):2355-63. PubMed ID: 1535660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of QSAR in dopamine interactions.
    Hansch C; Verma RP; Kurup A; Mekapati SB
    Bioorg Med Chem Lett; 2005 Apr; 15(8):2149-57. PubMed ID: 15808487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.